tiprankstipranks
OKYO Pharma to Highlight Innovations at BTIG Conference
Company Announcements

OKYO Pharma to Highlight Innovations at BTIG Conference

OKYO Pharma Limited Sponsored ADR (OKYO) has released an update.

Stay Ahead of the Market:

OKYO Pharma Limited is set to participate in the 4th Annual BTIG Ophthalmology Conference, showcasing their development of therapies for neuropathic corneal pain and dry eye disease, both significant conditions lacking FDA-approved treatments. The company will highlight its promising drug candidate, OK-101, which has shown positive results in recent trials. This involvement underscores OKYO Pharma’s commitment to advancing ophthalmic treatments in a rapidly growing market.

For further insights into OKYO stock, check out TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App